Your browser doesn't support javascript.
loading
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.
Nakahama, Kenji; Izumi, Motohiro; Yoshimoto, Naoki; Fukui, Mitsuru; Sugimoto, Akira; Nagamine, Hiroaki; Ogawa, Koichi; Sawa, Kenji; Tani, Yoko; Kaneda, Hiroyasu; Mitsuoka, Shigeki; Watanabe, Tetsuya; Asai, Kazuhisa; Kawaguchi, Tomoya.
Affiliation
  • Nakahama K; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan. nakahama_kenji@yahoo.co.jp.
  • Izumi M; Department of Pulmonary Medicine, Bell Land General Hospital, Sakai, Japan.
  • Yoshimoto N; Department of Pulmonary Medicine, Ishikiriseiki Hospital, Higashiosaka, Japan.
  • Fukui M; Department of Laboratory of Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Sugimoto A; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Nagamine H; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Ogawa K; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Sawa K; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Tani Y; Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Kaneda H; Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Mitsuoka S; Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Watanabe T; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Asai K; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
  • Kawaguchi T; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Asahimachi 1-4-3, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
Cancer Chemother Pharmacol ; 92(5): 381-390, 2023 11.
Article in En | MEDLINE | ID: mdl-37606723
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Alemania